Evaluation and strategies to generate mucosal antibodies against HIV-1 infection
Mucosal HIV infection is currently the leading cause of the global AIDS epidemic, with most infections occurring through sexual intercourse. A truly effective vaccine capable of protecting vaccines from HIV acquisition will likely require mucosal mediated immune protection. Previous non-human primat...
Main Author: | Klein, Katja |
---|---|
Published: |
St George's, University of London
2012
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.568768 |
Similar Items
-
Evolution and infectivity of HIV-1 subtype C viruses
by: Walker, Polly Rose
Published: (2006) -
A comparison of the effects of HIV-1 and HIV-2 infection on T lymphocyte turnover and their relationship to immune activation
by: Hegedus, Andrea
Published: (2013) -
T cell quality in HIV infection
by: Hickling, Stephen J.
Published: (2010) -
Investigation of B cell subsets and vaccination responses in HIV-1 infection and CVID
by: Hart, Melanie Sarah
Published: (2011) -
Genetic and functional analysis of APOBEC3G : a suppressor of HIV-1 infectivity
by: Newman, Edmund Nicholas
Published: (2006)